• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
Trending:
  • Kashmir
  • Elections
Sunday, June 21, 2026

Daily Times

Your right to know

  • HOME
  • Latest
  • Iran-Israel war
  • Gilgit Baltistan Election
  • Pakistan
    • Balochistan
    • Gilgit Baltistan
    • Khyber Pakhtunkhwa
    • Punjab
    • Sindh
  • World
  • Editorials & Opinions
    • Editorials
    • Op-Eds
    • Commentary / Insight
    • Perspectives
    • Cartoons
    • Letters to the Editor
    • Featured
    • Blogs
      • Pakistan
      • World
      • Lifestyle
      • Culture
      • Sports
  • Business
  • Sports
  • E-PAPER
    • Lahore
    • Islamabad
    • Karachi

Agencies

Three nurses suspended for negligence in Mayo Hospital injection mishap

Published on: March 12, 2025 1:34 AM

The Punjab Health Department released an inquiry report on Tuesday regarding the deaths of patients allegedly caused by a reaction to Ceftriaxone injections at Mayo Hospital.

Three nurses-Saima Seher, Nazia Hassan, and Sunaina Khalid-have been suspended for negligence.

The authorities have also issued show-cause notices to the suspended nurses and directed them to report to the Punjab Health Department. They have been instructed to submit written responses within seven days. The inquiry committee identified misconduct by the nurses, concluding that their negligence and malpractices in administering powdered injections (including reconstitution, dilution, and route of administration), along with bad dispensing practices of Ceftriaxone, led to adverse drug reactions in 16 patients on March 9, 2025, in the Chest Surgical Ward.

The report attributes the incident directly to the nurses’ negligence.

The Punjab government has banned the use of the Ceftriaxone injection in all hospitals following the ‘deaths’ of two patients at Mayo Hospital, Lahore, due to a severe reaction to the drug. Punjab’s Secretary of Health, Azmat Mahmood, confirmed the deaths and announced the formation of an investigation committee to probe the matter. He also immediately suspended the use of the injection across the province.

The Medical Superintendent (MS) of Jinnah Hospital revealed that their hospital had also received a stock of the Ceftriaxone injection from the Punjab Health Department.

However, following the fatal incidents at Mayo Hospital, the stock was returned as a precautionary measure.

According to sources, the Ceftriaxone injection was set to expire in May 2026, and its procurement was handled by the Director General (DG) Health Punjab, rather than Mayo Hospital itself.

Filed Under: Pakistan

Submit a Comment




Primary Sidebar




Latest News

US monitors Strait of Hormuz amid Iran warning

US-Iran talks begin amid Strait of Hormuz tensions

Israeli strikes shake Lebanon despite newly announced ceasefire

Keir Starmer faces pressure amid resignation speculation

Ishaq Dar engages regional leaders at Cairo diplomacy forum

Pakistan

Ishaq Dar engages regional leaders at Cairo diplomacy forum

Nation commemorates Shaheed Benazir Bhutto’s 73rd birthday

PM Shehbaz, Asim Munir join crucial US-Iran Switzerland talks

Trump hails PM, CDF Munir for helping US clinch Iran deal

Iran shuts Hormuz again; Swiss talks to start today

More Posts from this Category

Business

Lawmakers halt telecom bill over property rights concerns

Govt targets $4.5 billion market borrowing to diversify beyond bilateral loans in FY27

Gold prices edge down by Rs 43 per tola

Pakistan, ADB sign $700 million loan deal for insurance sector reforms

FPCCI committee charts roadmap to boost trade, investment growth

More Posts from this Category

World

US monitors Strait of Hormuz amid Iran warning

US-Iran talks begin amid Strait of Hormuz tensions

Israeli strikes shake Lebanon despite newly announced ceasefire

More Posts from this Category




Footer

Home
Lead Stories
Latest News
Editor’s Picks

Culture
Life & Style
Featured
Videos

Editorials
OP-EDS
Commentary
Advertise

Cartoons
Letters
Blogs
Privacy Policy

Contact
Company’s Financials
Investor Information
Terms & Conditions

Facebook
Twitter
Instagram
Youtube

© 2026 Daily Times. All rights reserved.

Manage Consent
To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.
Functional Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
  • Manage options
  • Manage services
  • Manage {vendor_count} vendors
  • Read more about these purposes
View preferences
  • {title}
  • {title}
  • {title}
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.